• Ms.Amy Lu
    Tel: 86-027-84306245

  • Mobile:
  • Tel:86-027-84306245
  • Fax:
  • URL:http://www.wondapharm.com
  • Province/state:Hubei
  • City:Wuhan
  • Street:Wuhan Private Science and Technology Park , Wuhan, China
  • MaxCard:
Home > Products >  High Quality Fevipiprant Anti-Hair Loss Pharmaceutical Powder

High Quality Fevipiprant Anti-Hair Loss Pharmaceutical Powder CAS NO.872365-14-5

  • Min.Order: 10 Gram
  • Payment Terms: L/C,T/T,
  • Product Details

Keywords

  • Fevipiprant
  • Fevipipran
  • cas 872365-14-5

Quick Details

  • ProName: High Quality Fevipiprant Anti-Hair Los...
  • CasNo: 872365-14-5
  • Molecular Formula: C19H17F3N2O4S
  • Appearance: white powder
  • Application: for hair-loss
  • DeliveryTime: 3 working days upon payment
  • PackAge: aluminum foil bag, customized
  • Port: Shenzhen, Shanghai, HK
  • ProductionCapacity: 500 Kilogram/Month
  • Purity: 99%
  • Storage: cool and dry place
  • Transportation: email:wonda-chem@outlook.com
  • LimitNum: 10 Gram

Superiority

1.high quality:

quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.

2.reasonable price:

we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.

3.low moq:

no worry about the low moq, our moq is 1 gram or even lower.

4.good service.

fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.

5. fast shipping and secure courier.

we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.

Details

Introduction oFevipiprant: 

Fevipiprant (INN; code name QAW039) is a drug being developed by Novartis which acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2 or CRTh2).[1][2][3
As of 2016, it is in Phase III[4] clinical trials for the treatment of asthma.[5]

Setipiprant (INN) (developmental code names ACT-129,968, KYTH-105) is a drug originally developed by Actelionwhich acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2).[1] It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients,[2][3] it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.

Main Information Fevipiprant: 

 
Fevipiprant

CAS 872365-14-5

Chemical name Fevipiprant;Fevipipran
 
 

Function of Fevipiprant: 

 

Fevipiprant is the drug for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of Setipiprant have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery.

 

 

Packing and shipping

 

 

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog